Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients

Clinical trial NCT00952380 · COMPLETED

Trial details

NCT number: NCT00952380
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Venous Thromboembolism

Start date: 2009-08-01
Primary completion: 2018-03-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.